Cost-effectiveness of stereotactic body radiotherapy in the treatment of non-small-cell lung cancer (NSCLC): a systematic review.

Sun, Hui; Jin, Chunlin; Wang, Huishan; Hu, Shanlian; Chen, Yingyao; Wang, Haiyin

Sun, Hui; Jin, Chunlin; Wang, Huishan; Hu, Shanlian; Chen, Yingyao; Wang, Haiyin.

Affiliation

Sun H; School of Public Health, Fudan University, Shanghai, China.
Jin C; National Health Commission Key Laboratory of Health Technology Assessment, School of Public Health, Fudan University, Shanghai, China Shanghai, China.
Wang H; Shanghai Health Development Research Center, Shanghai Medical Information Center, Shanghai, China.
Hu S; Shanghai Health Development Research Center, Shanghai Medical Information Center, Shanghai, China.
Chen Y; Department of Gastroenterology, Shanghai Songjiang District Central Hospital, Shanghai, China.
Wang H; School of Public Health, Fudan University, Shanghai, China.

Expert Rev Pharmacoecon Outcomes Res ; 22(5): 723-734, 2022 Jul.

Article de En | MEDLINE | ID: mdl-35249432

Sujet(s)
Mots clés

Non-small cell lung cancer; cost-effectiveness; stereotactic ablative body radiotherapy; systematic review

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Radiochirurgie / Carcinome pulmonaire non à petites cellules / Carcinome pulmonaire à petites cellules / Tumeurs du poumon Type d'étude: Health_economic_evaluation / Systematic_reviews Limites: Humans Langue: En Journal: Expert Rev Pharmacoecon Outcomes Res Sujet du journal: FARMACOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google